Medicus Pharma (NASDAQ:MDCX – Get Free Report) released its quarterly earnings results on Friday. The company reported ($0.18) earnings per share for the quarter, topping the consensus estimate of ($0.32) by $0.14, Zacks reports.
Medicus Pharma Stock Down 5.2 %
Shares of MDCX stock opened at $3.13 on Friday. The business’s 50 day moving average is $3.21. Medicus Pharma has a 12-month low of $1.80 and a 12-month high of $6.00.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on MDCX shares. Maxim Group began coverage on Medicus Pharma in a report on Tuesday, December 17th. They issued a “buy” rating and a $10.00 target price for the company. Brookline Capital Management upgraded Medicus Pharma to a “strong-buy” rating in a research note on Monday, December 23rd.
About Medicus Pharma
Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.
Read More
- Five stocks we like better than Medicus Pharma
- What is the Dogs of the Dow Strategy? Overview and Examples
- MarketBeat Week in Review – 03/24 – 03/28
- Investing In Preferred Stock vs. Common Stock
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Breakout Stocks: What They Are and How to Identify Them
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
